Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Revolution Medicines Inc (NQ: RVMD )

24.40 -0.58 (-2.32%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 8, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,270,018
Open 25.02
Bid (Size) 24.36 (10)
Ask (Size) 24.40 (34)
Prev. Close 24.98
Today's Range 23.79 - 25.57
52wk Range 14.08 - 34.16
Shares Outstanding 74,245,139
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Earnings Outlook For Revolution Medicines
  Revolution Medicines (NASDAQ:RVMD) is set to give its latest quarterly earnings report on Tuesday, 2022-08-09. Here's what investors need to know before the announcement. 
Via Benzinga
$10 Million Bet On This Financial Services Stock? 3 Stocks Insiders Are Buying
Although US stocks closed mixed on Monday, there were a few notable insider trades. 
Via Benzinga

Performance

YTD
-6.73%
-6.73%
1 Month
+11.11%
+11.11%
3 Month
+62.78%
+62.78%
6 Month
+8.11%
+8.11%
1 Year
-10.66%
-10.66%

More News

Read More
Revolution Medicines Stock Is Getting Hammered: Here's Why
Via Benzinga
The Daily Biotech Pulse: CDC AdComm Backs Novavax COVID-19 Vaccine, European Approval For PTC Therapeutics' Gene Therapy, Merck's Keytruda Flunks In Head, Neck Cancer Study
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Executives Buy More Than $12M Of 3 Stocks
Via Benzinga
Insiders Buy More Than $19M Of 3 Stocks
Via Benzinga
Earnings Scheduled For February 28, 2022
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 20, 2022
Via Benzinga
Earnings Scheduled For May 9, 2022
Via Benzinga
Revolution Medicines's Earnings Outlook
Via Benzinga
7 Stocks That Insiders Are Buying Now. Should You?
Via InvestorPlace
Children's Place And 2 Other Stocks Bought By Insiders
Via Benzinga
Insiders Buy More Than $3B Of 4 Stocks
Via Benzinga
It's a Done Deal: 365 Cannabis Sold to Akerna
Via Benzinga
Topics Cannabis
Exposures Cannabis
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2022
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
Via Benzinga
Exposures Product Safety
77 Biggest Movers From Yesterday
Via Benzinga
54 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 12, 2021
Via Benzinga
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
Via Benzinga
Exposures Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.